Protein Chemical Synthesis Combined with Mirror‐Image Phage Display Yields d‐Peptide EGF Ligands that Block the EGF–EGFR Interaction
- 3 July 2019
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 20 (16) , 2079-2084
Abstract
The epidermal growth factor (EGF) pathway, being overactive in a number of cancers, is a good target for clinical therapy. Although several drugs targeting the EGF receptor (EGFR) are on the market, tumours acquire resistance very rapidly. As an alternative, small molecules and peptides targeting EGF have been developed, although with moderate success. Herein, we report the use of mirror‐image phage display technology to discover protease‐resistant peptides with the capacity to inhibit the EGF–EGFR interaction. After the chemical synthesis of the enantiomeric protein d‐EGF, two phage‐display peptide libraries were used to select binding sequences. The d versions of these peptides bound to natural EGF, as confirmed by surface acoustic waves (SAWs). High‐field NMR spectroscopy showed that the best EGF binder, d‐PI_4, interacts preferentially with an EGF region that partially overlaps with the receptor binding interface. Importantly, we also show that d‐PI_4 efficiently disrupts the EGF–EGFR interaction. This methodology represents a straightforward approach to find new protease‐resistant peptides with potential applications in cancer therapy.Keywords
Funding Information
- Generalitat de Catalunya (2017SGR0998)
This publication has 38 references indexed in Scilit:
- Epidermal growth factor receptor targeting in cancer: A review of trends and strategiesBiomaterials, 2013
- Chemical synthesis and X-ray structure of a heterochiral {D-protein antagonist plus vascular endothelial growth factor} protein complex by racemic crystallographyProceedings of the National Academy of Sciences, 2012
- Through the looking glass – a new world of proteins enabled by chemical synthesisJournal of Peptide Science, 2012
- Corruption of phage display libraries by target-unrelated clones: Diagnosis and countermeasuresAnalytical Biochemistry, 2010
- The NMR solution structure of human epidermal growth factor (hEGF) at physiological pH and its interactions with suraminBiochemical and Biophysical Research Communications, 2010
- From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathwayProceedings of the National Academy of Sciences, 2010
- Epidermal Growth Factor Receptor–Mediated Signal Transduction in the Development and Therapy of GliomasClinical Cancer Research, 2006
- Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular DomainsCell, 2002
- Synthesis and biological activity of N-terminal-truncated derivatives of human epidermal growth factor (h-EGF)Peptides, 1995
- Synthesis of a 53-residue peptide with EGF activityJournal of the Chemical Society, Chemical Communications, 1984